Finance Home - My Yahoo - Yahoo! - Help

Tuesday, November 10, 2009, 6:53AM ET - U.S. Markets open in 2 hours and 37 minutes. Dow  2.03% Nasdaq  0.00%

Orexigen Therapeutics, Inc. (OREX)

On Nov 9: 7.12   0.00 (0.00%)

MORE ON OREX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Thu, Nov 5, 2009 • OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 5) • Orexigen 3rd-quarter loss narrows on lower costs AP (Thu, Nov 5) • New Star Analyst Rankings for Orexigen Therapeutics, Inc. StarMine (Thu, Nov 5) Wed, Nov 4, 2009 • Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN (Wed, Nov 4) • OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or EDGAR Online (Wed, Nov 4) • Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results PR Newswire (Wed, Nov 4) • Vivus shares dive following 3rd-quarter report AP (Wed, Nov 4) • Q3 2009 OREXIGEN THERAPEUTICS INC Earnings Release - After Market Close CCBN (Wed, Nov 4) Tue, Nov 3, 2009 • [video] Stocks Under $10: 2 Beaten Down Buys at TheStreet.com (Tue, Nov 3) Mon, Nov 2, 2009 • Amylin signs weight-loss drug deal with Takeda AP (Mon, Nov 2) • Don't Expect Amylin to Eat the Obesity Market's Lunch at Seeking Alpha (Mon, Nov 2) • Amylin Strikes First on Obesity Zacks.com (Mon, Nov 2) Fri, Oct 30, 2009 • Friday At The Fat Fight at CNBC (Fri, Oct 30) Thu, Oct 29, 2009 • Orexigen(R) Therapeutics Schedules November 4, 2009 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2009 PR Newswire (Thu, Oct 29) Wed, Oct 28, 2009 • Vivus, Analyst in Obesity Drug Side-Effect Spat at TheStreet.com (Wed, Oct 28) Tue, Oct 27, 2009 • Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society PR Newswire (Tue, Oct 27) • Arena: 2nd weight loss trial shows cardiac benefit at Reuters (Tue, Oct 27) Mon, Oct 26, 2009 • Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues Wall Street Transcript (Mon, Oct 26) • Sector Snap: Obesity drug makers gain ground AP (Mon, Oct 26) • Vivus' Mr. Wilson Goes To Washington at CNBC (Mon, Oct 26) Older Headlines - Download Recent Headlines View headlines from: Mon, Oct 26, 2009Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009Mon, Sep 7, 2009Mon, Aug 31, 2009Mon, Aug 24, 2009 Add OREX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage